Monkeypox vaccine attracts interest for Bavarian as virus spreads

Bavarian, which signed a supply contract with an unnamed European country last week, reports it is in dialog with several countries, some yet to be affected, concerning the firm’s monkeypox vaccine.
Photo: Bavarian Nordic / PR
Photo: Bavarian Nordic / PR
By Christian Wienberg, bloomberg

Bavarian Nordic A/S, the only maker of an approved vaccine to prevent monkeypox, is in talks to supply several countries that have identified cases of the viral infection.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
!
!
Must contain at least 6 characters
!
Must contain at least 2 characters
!
Must contain at least 2 characters

Get full access for you and your coworkers

Start a free company trial today

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

!
Newsletter terms

Front page now

Further reading